The inclusion of cancer in the new research partnership suggests GSK's continuing interest in the therapy area, despite its divestment of its marketed oncology portfolio to Novartis. Being first ...
International biotechnology company GlaxoSmithKline is moving its ... step to strengthen its presence in the Greater Boston area. The research and development teams will relocate from Rockville ...
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...